Non-small-cell lung cancer - Stalemate or progress?

被引：60

作者：

Carney, DN ^{[1
]}

Hansen, HH

机构：

[1] Mater Misericordiae Hosp, Dublin 7, Ireland

[2] Finsen Ctr, DK-2100 Copenhagen, Denmark

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 17期

关键词：

D O I：

10.1056/NEJM200010263431710

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1261 / 1262

页数：2

共 15 条

[1]

ALBERTI W, 1995, BRIT MED J, V311, P899

[2] Molecular pathogenesis of lung cancer [J].

Fong, KM ;

Sekido, Y ;

Minna, JD .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (06) :1136-1152

[3]

HONG WK, 2000, LUNG CANCER S4, V29, P41

[4] A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer. [J].

Keller, SM ;

Adak, S ;

Wagner, H ;

Herskovic, A ;

Komaki, R ;

Brooks, BJ ;

Perry, MC ;

Livingston, RB ;

Johnson, DH .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (17) :1217-1222

[5]

KELLY K, 1999, P AN M AM SOC CLIN, V18, pA461

[6]

MARINO P, 1995, CANCER, V76, P593, DOI 10.1002/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO

[7]

2-N

[8]

Pritchard RS, 1997, ANN INTERN MED, V126, P670, DOI 10.7326/0003-4819-125-9-199611010-00003

[9]

Pritchard RS, 1996, ANN INTERN MED, V125, P723, DOI 10.7326/0003-4819-125-9-199611010-00003

[10] Preresectional chemotherapy in stage IIIA non-small-cell lung cancer:: a 7-year assessment of a randomized controlled trial [J].

Rosell, R ;

Gómez-Codina, J ;

Camps, C ;

Sánchez, JJ ;

Maestre, J ;

Padilla, J ;

Cantó, A ;

Abad, A ;

Roig, J .

LUNG CANCER, 1999, 26 (01) :7-14

← 1 2 →